Terms: = Kidney tumors AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
62 results:
1. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell transcriptome sequencing reveals aberrantly activated inter-tumor cell signaling pathways in the development of clear cell renal cell carcinoma.
Zhang J; Liu F; Guo W; Bi X; Yuan S; Shayiti F; Pan T; Li K; Chen P
J Transl Med; 2024 Jan; 22(1):37. PubMed ID: 38191424
[TBL] [Abstract] [Full Text] [Related]
3. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
4. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
5. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract] [Full Text] [Related]
6. EMX2OS targeting IGF2BP1 represses Wilms' tumour stemness,epithelial-mesenchymal transition and metastasis.
Zhang HM; Cui MY; Chen ZH
J Genet; 2023; 102():. PubMed ID: 36722215
[TBL] [Abstract] [Full Text] [Related]
7. Diallyl Trisulfide Suppresses the Renal Cancer Stem-like Cell Properties via Nanog.
Zhang T; Cao W; Sun H; Yu D; Zhong C
Nutr Cancer; 2023; 75(3):971-979. PubMed ID: 36562732
[TBL] [Abstract] [Full Text] [Related]
8. Generation of a human iPSC line (MPIi008-A) from a patient with Denys-Drash syndrome.
Doeser MC; Krygin J; Röpke A; Han D; Wedlich-Söldner R; Schöler HR; Pavenstädt H; Kim KP
Stem Cell Res; 2022 Jul; 62():102826. PubMed ID: 35667217
[TBL] [Abstract] [Full Text] [Related]
9. Primary renal sarcoma with SS18::pou5f1 gene fusion.
Argani P; Matoso A; Gross JM; Zhang Y; SoRelle JA; Gagan J; Antonescu CR; Palsgrove D
Genes Chromosomes Cancer; 2022 Sep; 61(9):572-577. PubMed ID: 35521683
[TBL] [Abstract] [Full Text] [Related]
10. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis.
Tung MC; Lin YW; Lee WJ; Wen YC; Liu YC; Chen JQ; Hsiao M; Yang YC; Chien MH
Cell Death Dis; 2022 Apr; 13(4):400. PubMed ID: 35461314
[TBL] [Abstract] [Full Text] [Related]
11. Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue.
Otter M; Csader S; Keiser M; Oswald S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008681
[TBL] [Abstract] [Full Text] [Related]
12. Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases.
Wang G; Amin MB; Grossmann P; Ptáková N; Hayes M; Hartmann A; Agaimy A; Lopez JI; Michal M; Hes O
Virchows Arch; 2022 Feb; 480(2):349-358. PubMed ID: 34775513
[TBL] [Abstract] [Full Text] [Related]
13. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro.
Choi HS; Ko YS; Jin H; Kang KM; Ha IB; Jeong H; Song HN; Kim HJ; Jeong BK
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500557
[TBL] [Abstract] [Full Text] [Related]
14. Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma.
Siljee S; Milne B; Brasch HD; Bockett N; Patel J; Davis PF; Kennedy-Smith A; Itinteang T; Tan ST
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33916968
[TBL] [Abstract] [Full Text] [Related]
15. Aggressive myoepithelial carcinoma with EWSR1-pou5f1 fusion highly responsive to Ewing sarcoma combination chemotherapy.
Shenoy N
Cancer; 2020 Dec; 126(24):5198-5201. PubMed ID: 33048366
[TBL] [Abstract] [Full Text] [Related]
16. Steroid receptor RNA activator inhibits the migration, invasion and stemness characteristics of renal cell carcinoma cells.
Zhang C; Zhu N; Liu C; Wu H; Yin Y; Shi Y; Liao D; Qin L
Int J Mol Med; 2020 Nov; 46(5):1765-1776. PubMed ID: 33000206
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of oct4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract] [Full Text] [Related]
18. Critical role of SOX2-IGF2 signaling in aggressiveness of bladder cancer.
Chiu YF; Wu CC; Kuo MH; Miao CC; Zheng MY; Chen PY; Lin SC; Chang JL; Wang YH; Chou YT
Sci Rep; 2020 May; 10(1):8261. PubMed ID: 32427884
[TBL] [Abstract] [Full Text] [Related]
19. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
[TBL] [Abstract] [Full Text] [Related]
20. Farnesoid X receptor and liver X receptors regulate oct3/4 expression by multiple feedback regulating system in normal renal-derived cells and renal adenocarcinoma cells.
Fujino T; Sugizaki K; Kato R; Beppu M; Murakami S; Lee H; Oshima T; Hayakawa M
J Toxicol Sci; 2020; 45(1):25-35. PubMed ID: 31932555
[TBL] [Abstract] [Full Text] [Related]
[Next]
